| Drug Type Radiolabeled antibody, Diagnostic radiopharmaceuticals | 
| Synonyms Iodine-124-labelled F-16 scFv antibody, Monoclonal antibody F-16-I-124, Monoclonal antibody F16 I 124 + [4] | 
| Target | 
| Action inhibitors, enhancers | 
| Mechanism tenascin inhibitors(Tenascin inhibitors), PET imaging(Positron-emission tomography enhancers) | 
| Therapeutic Areas | 
| Active Indication- | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization- | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhaseDiscontinuedPhase 2 | 
| First Approval Date- | 
| Regulation- | 

| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Neoplasms | Phase 2 | - | - | |
| Neoplasms | Phase 2 | - | - | |
| Solid tumor | Phase 2 | Italy  | - | - | 






